• Diagens Biotechnology Nears IPO After Passing HKSE Listing Hearing
Diagens Biotechnology - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    194 followers

  • Elon Musk

    Elon Musk

    78 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    56 followers

  • Jack Dorsey

    Jack Dorsey

    39 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    196 followers

  • Anthropic

    Anthropic

    39 followers

  • OpenAI

    OpenAI

    21 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeDiagens Biotechnology
Diagens Biotechnology logo

Diagens Biotechnology

0 followers

About Diagens Biotechnology

Deshi Biotech is a Hangzhou-based biotechnology company focused on life sciences research and development. The company operates in the Chinese biotech sector, pursuing innovations in areas related to biomedical research and biotechnical applications. While public details are limited on this page, the firm appears to be engaged in scientific development and biotechnology activities within China.

Recent News

No recent news for this company.

Recent Deals

Diagens Biotechnology Nears IPO After Passing HKSE Listing Hearing

March 15, 2026

Key Team Members

Benjamin Charles

CEO, Co-founder

Patrick Collombat

Co-founder

Hélène Sicard

Chief Development Officer

Klara Owen

Chief Medical Officer

Key Facts

HQ Location

Hangzhou, China

Employees

1 - 10

Status

Private

Website

https://diagens.com